Indaptus Therapeutics logo

Indaptus Therapeutics share price today

(INDP)

Indaptus Therapeutics share price is $0.95 & ₹81.52 as on 7 Jan 2025, 2.30 'hrs' IST

$0.95

0.07

(7.95%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Indaptus Therapeutics share price in Dollar and Rupees. Guide to invest in Indaptus Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Indaptus Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Indaptus Therapeutics share price movements

  • Today's Low: $0.89
    Today's High: $1.00

    Day's Volatility :11.4%

  • 52 Weeks Low: $0.81
    52 Weeks High: $3.10

    52 Weeks Volatility :73.87%

Indaptus Therapeutics Returns

PeriodIndaptus Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-23.48%
-8.4%
0.0%
6 Months
-58.49%
-3.8%
0.0%
1 Year
-53.64%
-0.1%
0.0%
3 Years
-83.33%
2.9%
-19.8%

Indaptus Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.88
Open
$0.95
Today's High
$1.0
Today's Low
$0.886
Market Capitalization
$10.1M
Today's Volume
$18.7K
52 Week High
$3.1
52 Week Low
$0.81
Revenue TTM
$0.0
EBITDA
$-16.5M
Earnings Per Share (EPS)
$-1.7
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-127.04%

How to invest in Indaptus Therapeutics from India?

It is very easy for Indian residents to invest directly in Indaptus Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Indaptus Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Indaptus Therapeutics or INDP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Indaptus Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Indaptus Therapeutics shares which would translate to 0.903 fractional shares of Indaptus Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Indaptus Therapeutics, in just a few clicks!

Returns in Indaptus Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Indaptus Therapeutics investment value today

Current value as on today

₹53,223

Returns

₹46,777

(-46.78%)

Returns from Indaptus Therapeutics Stock

₹50,000 (-50%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Indaptus Therapeutics

-13%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Indaptus Therapeutics on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -13% less investors are searching Indaptus Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Indaptus Therapeutics

  • Vanguard Group Inc

    2.13%

  • Investment House LLC

    0.83%

  • Geode Capital Management, LLC

    0.61%

  • Strategy Asset Managers LLC

    0.38%

  • Pine Valley Investments Ltd Liability Co

    0.37%

  • Renaissance Technologies Corp

    0.23%

Analyst Recommendation on Indaptus Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Indaptus Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Indaptus Therapeutics

What analysts predicted

Upside of 794.74%

Current:

$0.95

Target:

$8.50

Insights on Indaptus Therapeutics

  • Price Movement

    In the last 1 month, INDP stock has moved down by -15.4%
  • INDP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 73.7%
  • INDP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 140.1%

Indaptus Therapeutics Technicals Summary

Sell

Neutral

Buy

Indaptus Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Indaptus Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Indaptus Therapeutics Inc
-12.0%
-58.49%
-53.64%
-83.33%
-97.8%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Indaptus Therapeutics Inc
NA
NA
NA
-1.79
-1.27
-0.71
NA
1.44
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Indaptus Therapeutics Inc
Buy
$10.1M
-97.8%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Indaptus Therapeutics

the indaptus goal is simple: to cure disease with the ability to harness both the body’s innate and adaptive immune responses, we believe we are uniquely positioned to revolutionize the treatment of cancer and certain infectious diseases. building on the observation that tumor regression can occur in the setting of bacterial infection, we have developed a proprietary platform that exploits bacteria’s natural ability to activate both innate and adaptive cellular immune pathways. leveraging our novel insights into the levels and ratios of activating signals needed to safely elicit a broad immune response, we are creating and advancing a pipeline of proprietary, attenuated and killed non-pathogenic gram-negative bacterial candidates designed to be widely accessible, with broad anti-tumor and anti-viral activity.
Organization
Indaptus Therapeutics
Employees
7
CEO
Dr. Michael J. Newman Ph.D.
Industry
Healthcare

Management People of Indaptus Therapeutics

NameTitle
Dr. Michael J. Newman Ph.D.
Founder, Chief Scientific Officer & Director
Mr. Walt Addison Linscott Esq.
Chief Operating Officer
Mr. Nir Sassi
CFO, Secretary & Treasurer
Dr. Roger J. Waltzman M.B.A., M.D.
Chief Medical Officer

Important FAQs about investing in Indaptus Therapeutics from India :

What is Indaptus Therapeutics share price today?

Indaptus Therapeutics share price today stands at $0.95, Open: $0.95 ; Previous Close: $0.88 ; High: $1.00 ; Low: $0.89 ; 52 Week High: $3.10 ; 52 Week Low: $0.81. The stock opens at $0.95, after a previous close of $0.88. The stock reached a daily high of $1.00 and a low of $0.89, with a 52-week high of $3.10 and a 52-week low of $0.81.

Can Indians buy Indaptus Therapeutics shares?

Yes, Indians can invest in the Indaptus Therapeutics (INDP) from India.

With INDmoney, you can buy Indaptus Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Indaptus Therapeutics at zero transaction cost.

How can I buy Indaptus Therapeutics shares from India?

It is very easy to buy Indaptus Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Indaptus Therapeutics be purchased?

Yes, you can buy fractional shares of Indaptus Therapeutics with INDmoney app.

What are the documents required to start investing in Indaptus Therapeutics stocks?

To start investing in Indaptus Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Indaptus Therapeutics

Today’s highest price of Indaptus Therapeutics (INDP) is $1.00.

Today’s lowest price of Indaptus Therapeutics (INDP) is $0.89.

What is today's market capitalisation of Indaptus Therapeutics

Today's market capitalisation of Indaptus Therapeutics INDP is 10.1M

What is the 52 Week High and Low Range of Indaptus Therapeutics

  • 52 Week High

    $3.10

  • 52 Week Low

    $0.81

What are the historical returns of Indaptus Therapeutics?

  • 1 Month Returns

    -12%

  • 3 Months Returns

    -58.49%

  • 1 Year Returns

    -53.64%

  • 5 Years Returns

    -97.8%

Who is the Chief Executive Officer (CEO) of Indaptus Therapeutics

Dr. Michael J. Newman Ph.D. is the current Chief Executive Officer (CEO) of Indaptus Therapeutics.